منابع مشابه
Guillain-Barré syndrome following pandemic (H1N1) 2009 influenza A immunisation in Victoria: a self-controlled case series.
OBJECTIVES To determine the relative incidence (RI) of Guillain-Barré syndrome (GBS) in a single Australian state following pandemic (H1N1) 2009 influenza A immunisation (monovalent vaccine or seasonal trivalent influenza vaccine [TIV]) in 2009-2010. DESIGN, SETTING AND PARTICIPANTS Active GBS surveillance (cases assessed by two neurologists according to the Brighton criteria) from 30 Septemb...
متن کاملMapping immunisation coverage and conscientious objectors to immunisation in NSW.
The Australian Childhood Immunisation Register (ACIR) commenced operation on 1 January 1996 and is now an important component of the Immunise Australia Program. Immunisations are generally notified to the ACIR either by electronic means—by email or the internet—or by hard copy notification forms. Parents with children who have a personal, philosophical, religious or medical belief that immunisa...
متن کاملImportance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines.
Because of the advent of a new influenza A H1N1 strain, many countries have begun mass immunisation programmes. Awareness of the background rates of possible adverse events will be a crucial part of assessment of possible vaccine safety concerns and will help to separate legitimate safety concerns from events that are temporally associated with but not caused by vaccination. We identified backg...
متن کاملImmunisation, rehydration, and transfusion.
The results of a survey of 64 Scottish general practitionerhospitals showed that in 1980 these hospitals contained3-3% of available staffed beds in Scotland; 13 6% of theresident population had access for initial hospital care,and 14-5% of Scottish general practitioners were on theirstaffs. During the year of the survey they discharged 1-8%of all non-surgical patients, t...
متن کاملImmunisation against meningococcus B.
www.thelancet.com Vol 382 September 7, 2013 857 in 2000 under circumstances of uncertainty about efficacy and low (but in that case rising) disease incidence. A decision to introduce the Novartis vaccine, which is not really a meningococcus B but actually a broader, generic meningococcal vaccine, and to give it to adolescents and young adults who have the highest carriage rates could have been ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Australian Prescriber
سال: 2010
ISSN: 0312-8008,1839-3942
DOI: 10.18773/austprescr.2010.029